var data={"title":"Mebendazole: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Mebendazole: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6511?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=mebendazole-patient-drug-information\" class=\"drug drug_patient\">see &quot;Mebendazole: Patient drug information&quot;</a> and <a href=\"topic.htm?path=mebendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Mebendazole: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46303332\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Emverm</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191554\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Vermox</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191598\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Anthelmintic</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191557\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Ancylostoma duodenale</i> or <i>Necator americanus</i> (hookworm):</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Manufacturer&rsquo;s labeling: </i>100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Alternate dosing:</i> 500 mg as a single dose (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ascariasis (roundworm): </b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Manufacturer&rsquo;s labeling: </i>100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Alternate dosing:</i> 500 mg as a single dose (Parasitic Infections 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Enterobiasis (pinworm): </b>Oral: 100 mg as a single dose; repeat in 3 weeks if not cured with initial treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Trichuriasis (whipworm): </b>Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Capillariasis (off-label use):</b> Oral: 200 mg twice daily for 20 days (CDC 2012). Additional data may be necessary to further define the role of mebendazole in this condition.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Echinococcus, cystic (off-label use):</b> Oral: 40 to 50 mg/kg/day in 3 divided doses for 3 to 6 months (CDC 2014; Franchi 1999). Additional data may be necessary to further define the role of mebendazole in this condition.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Trichinellosis (<i>Trichinella spiralis</i>) (off-label use): </b>Oral: 200 to 400 mg 3 times daily for 3 days, followed by 400 to 500 mg 3 times daily for 10 days (CDC 2016b). Additional data may be necessary to further define the role of mebendazole in this condition.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Trichostrongyliasis (off-label use): </b>Oral: 100 mg twice daily for 3 days (Farahmandian 1977)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Toxocariasis (off-label use):</b> Oral: 100 to 200 mg twice daily for 5 days (CDC 2013). Additional data may be necessary to further define the role of mebendazole in this condition.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191577\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=mebendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Mebendazole: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Intestinal nematode infection (hookworm, pinworm, roundworm, whipworm):</b> Children &ge;2 years and Adolescents: Oral: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Capillariasis (off-label use):</b> Limited data available: Children and Adolescents: Oral: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Trichinellosis (off-label use):</b> Limited data available: Children and Adolescents: Oral: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Toxocariasis (off-label use):</b> Children and Adolescents: Oral: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191558\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13906823\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13906824\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling; however, undergoes extensive hepatic metabolism; use with caution as systemic exposure may be increased.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46303333\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Chewable, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Emverm: 100 mg [contains corn starch, fd&amp;c yellow #6 (sunset yellow), saccharin sodium]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20452591\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13880659\" class=\"block foccan drugH1Div\"><span class=\"drugH1\">Dosage Forms: Canada</span>\n    <p style=\"text-indent:0em;display:inline\">Information with regard to form, strength, and availability of products uniquely available in Canada but currently not available in the US. Refer also to Dosage forms.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Vermox 100 mg [scored]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49296536\" class=\"block accres drugH1Div\"><span class=\"drugH1\">Prescribing and Access Restrictions</span>\n    <p style=\"text-indent:0em;display:inline\">Vermox 500 mg chewable tablets are only available through Johnson &amp; Johnson's Vermox Donation Program to help reduce the burden of soil-transmitted helminths in endemic countries. There are currently no plans to make Vermox 500 mg chewable tablets commercially available.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F803167\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Administer with or without food. Tablets may be chewed, swallowed whole, or crushed and mixed with food.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191534\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Intestinal nematode infection:</b> Treatment of patients &ge;2 years of age with GI infections caused by <i>Ancylostoma duodenale</i> or <i>Necator americanus</i> (hookworms), <i>Ascaris lumbricoides</i> (roundworms), <i>Enterobius vermicularis</i> (pinworms), and <i>Trichuris trichiura</i> (whipworms).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25730778\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Capillariasis; Echinococcosis, cystic (Echinococcus granulosus); Trichinellosis (Trichinella spiralis); Trichostrongyliasis; Toxocariasis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9500697\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Mebendazole may be confused with metroNIDAZOLE</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191526\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal pain, anorexia, diarrhea, flatulence, nausea, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hepatic: Hepatitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&lt;1%, postmarketing, and/or case reports: Abnormal hepatic function tests, agranulocytosis, alopecia, anaphylaxis, angioedema, decreased ejaculate volume (Parasitic Infections 2013), dizziness, glomerulonephritis, hepatitis, hypersensitivity reaction, leukopenia (Parasitic Infections 2013), neutropenia, seizure, skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191537\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to mebendazole or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191523\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bone marrow suppression: Neutropenia and agranulocytosis have been reported with high doses and prolonged use. Monitor CBC if used at higher doses or for a prolonged duration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hepatic impairment: Use with caution; systemic exposure may be increased with hepatic impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Experience with use in children &lt;2 years of age is limited; convulsions have been reported postmarketing in pediatric patients &lt;1 year.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299650\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191528\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9594&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aminoquinolines (Antimalarial): May decrease the serum concentration of Anthelmintics.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CarBAMazepine: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cimetidine: May increase the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Fosphenytoin: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MetroNIDAZOLE (Systemic): Mebendazole may enhance the adverse/toxic effect of MetroNIDAZOLE (Systemic). Particularly the risk for Stevens-Johnson syndrome or toxic epidermal necrolysis may be increased. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenytoin: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191549\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Mebendazole serum levels may be increased if taken with food. Management: Administer without regard to meals.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13386518\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Untreated soil transmitted helminth infections during pregnancy are associated with adverse outcomes (eg, maternal iron deficiency anemia, low birth weight, neonatal and maternal death). Treatment of pinworm in pregnancy with mebendazole may be considered; however, the CDC suggests postponing therapy until the third trimester when possible (CDC 2016a).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191540\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Mebendazole is present in breast milk. According to the manufacturer, the decision to continue or discontinue breastfeeding during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother. Current guidelines note that breastfeeding does not need to be withheld during therapy (CDC 2016a).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191531\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Periodic hematologic, hepatic, and renal function; check  for helminth ova in feces within 3-4 weeks following the initial therapy</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191522\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Inhibits the formation of helminth microtubules; selectively and irreversibly blocks glucose uptake and other nutrients in susceptible adult intestine-dwelling helminths</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191536\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Oral: Poor; 5% to 10%; increased with food (Dayan 2003)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Distribution: V<sub>d</sub>: 1 to 2 L/kg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Protein binding: 90% to 95%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Extensively hepatic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: 3 to 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Primarily feces (as unchanged drug and primary metabolite); urine (&lt;2%)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46312663\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Emverm Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (1): $442.80</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191542\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Adec (TW);</li>\n      <li>Anelmin (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Antiox (PH);</li>\n      <li>Astazole (ET);</li>\n      <li>Azoel (PY);</li>\n      <li>Benda (TH, VN);</li>\n      <li>Bendazole (JO);</li>\n      <li>Benhol (LK);</li>\n      <li>Big-Ben (TH);</li>\n      <li>Combantrin-1 (NZ);</li>\n      <li>Combantrin-1 with mebendazole (AU);</li>\n      <li>Conquer (TW);</li>\n      <li>Cremox (BD);</li>\n      <li>D-Worm (ZA);</li>\n      <li>Daxol (PY);</li>\n      <li>Diacor (CL);</li>\n      <li>Diazolen (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Endal (LK);</li>\n      <li>Fugacar (TH, VN);</li>\n      <li>Helben (BD);</li>\n      <li>Hitolin (TW);</li>\n      <li>Kaizole (TW);</li>\n      <li>L-Ombrix (MX);</li>\n      <li>Lomper (ES);</li>\n      <li>Madnil (BD);</li>\n      <li>Mebedal (MX);</li>\n      <li>Mebendazol (MX);</li>\n      <li>Mebensole (MX);</li>\n      <li>Mebex (ET, IN);</li>\n      <li>Mebez (ET);</li>\n      <li>Mebezol (TW);</li>\n      <li>Mebzol (AE, BH, KW, QA);</li>\n      <li>Nemasole (AR);</li>\n      <li>Pantelmin (AT, BR, CO, EC, PE, PT, PY, UY, VE);</li>\n      <li>Quemox (ET, MY, TH);</li>\n      <li>Revapol (MX);</li>\n      <li>Ribamox (BD);</li>\n      <li>Ridworm (AU);</li>\n      <li>Surfont (DE);</li>\n      <li>Thelmox (ET);</li>\n      <li>Toloxim (PT);</li>\n      <li>Vermazol (TR);</li>\n      <li>Vermicol (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Vermid (KR);</li>\n      <li>Vermin-Dazol (MX);</li>\n      <li>Vermoks (UA);</li>\n      <li>Vermox (AE, AU, BB, BE, BF, BG, BH, BJ, BM, BS, BZ, CH, CI, CN, CR, CY, CZ, DE, DK, DO, EE, EG, ET, GB, GH, GM, GN, GR, GT, GY, HK, HN, HR, HU, ID, IE, IL, IQ, IR, IS, IT, JM, JO, KE, KW, LB, LK, LR, LT, LU, LV, LY, MA, ML, MR, MT, MU, MW, MX, NE, NG, NI, NL, NO, NZ, OM, PA, PK, PL, PR, QA, RO, RU, SA, SC, SD, SE, SI, SK, SL, SN, SR, SV, SY, TN, TR, TT, TZ, UG, YE, ZA, ZM, ZW);</li>\n      <li>Vertizole (MX);</li>\n      <li>Warca (TH);</li>\n      <li>Wormazol (AE, BH, QA, SA);</li>\n      <li>Wormgo (ZA);</li>\n      <li>Wormin (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IN, IQ, IR, JO, KE, KW, LB, LK, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);</li>\n      <li>Wormizol (LK);</li>\n      <li>Zadomen (MY)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Allgayer H, Z&auml;hringer J, Bach P, Bircher J. Lack of effect of haemodialysis on mebendazole kinetics: studies in a patient with echinococcosis and renal failure. <i>Eur J Clin Pharmacol</i>. 1984;27(2):243-245.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/6499904/pubmed\" target=\"_blank\" id=\"6499904\">6499904</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Canete R, Escobedo AA, Gonzalez ME, et al, &quot;Randomized Clinical Study of Five Days Apostrophe Therapy With Mebendazole Compared to Quinacrine in the Treatment of Symptomatic Giardiasis in Children,&quot; <i>World J Gastroenterol</i>, 2006, 12(39):6366-70.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/17072963/pubmed\" target=\"_blank\" id=\"17072963\">17072963</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"CDC.2012\"></a>Centers for Disease Control and Prevention (CDC). Parasites - capillariasis (also known as capillaria infection). <a href=\"http://www.cdc.gov/parasites/capillaria/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/capillaria/health_professionals/index.html</a>. Updated January 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"CDC.2014\"></a>Centers for Disease Control and Prevention (CDC). Parasites - echinococcus. Available at <a href=\"http://www.cdc.gov/parasites/echinococcus/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/echinococcus/health_professionals/index.html</a>. Updated July 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"CDC.2016a\"></a>Centers for Disease Control and Prevention (CDC). Parasites - enterobiasis (also known as Pinworm Infection). Available at <a href=\"http://www.cdc.gov/parasites/pinworm/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/pinworm/health_professionals/index.html</a>. Updated February 2016a.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/CDC 2016a/pubmed\" target=\"_blank\" id=\"CDC 2016a\">CDC 2016a</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"CDC.2016b\"></a>Centers for Disease Control and Prevention (CDC). Parasites &ndash; trichinellosis (also known as trichinosis). Available at <a href=\"http://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html</a>. Updated November 2016b.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/CDC 2016b/pubmed\" target=\"_blank\" id=\"CDC 2016b\">CDC 2016b</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"CDC.2013\"></a>Centers for Disease Control and Prevention (CDC). Parasites - toxocariasis (also known as roundworm infection). <a href=\"http://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html</a>. Updated January 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chandy E and McCarthy J, &quot;Evidence Behind the WHO Guidelines: Hospital Care for Children: What Is the Most Appropriate Treatment for Giardiasis?&quot; <i>J Trop Pediatr</i>, 2009, 55(1):5-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/18786986/pubmed\" target=\"_blank\" id=\"18786986\">18786986</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"1488697\"></a>Chunlertrith K, Mairiang P, Sukeepaisarnjaroen W. Intestinal capillariasis: a cause of chronic diarrhea and hypoalbuminemia. Southeast Asian J Trop Med Public Health. 1992;23(3):433-436.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"12745134\"></a>Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. <i>Acta Tropica</i>. 2003;86(2-3):141-159.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    de Silva N, Guyatt H, and Bundy D, &ldquo;Anthelmintics. A Comparative Review of Their Clinical Pharmacology,&rdquo; <i>Drugs</i>, 1997, 53(5):769-88.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/9129865/pubmed\" target=\"_blank\" id=\"9129865\">9129865</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Drugs for parasitic infections. <i>Med Lett Drugs Ther.</i> 2013;11(suppl):e1-e31.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Emverm (mebendazole) [prescribing information]. Horsham, PA: Amedra Pharmaceuticals; June 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"318981\"></a>Farahmandian I, Arfaa F, Jalali H, Reza M. Comparative studies on the evaluation of the effect of new anthelminthics on various intestinalhelminthiasis in Iran. Effects of anthelminthics on intestinal helminthiasis. <i>Chemotherapy</i>. 1977;23(2):98-105.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/318981/pubmed\" target=\"_blank\" id=\"318981\">318981</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"10476732\"></a>Franchi C, Di Vico B, Teggi A. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. <i>Clin Infect Dis</i>. 1999;29(2):304-309.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/10476732/pubmed\" target=\"_blank\" id=\"10476732\">10476732</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"7135477\"></a>Horstmann RD, Kern P, Volkmer KJ, Dietrich M. Observations on mebendazole vs. thiabendazole in the treatment of human trichinellosis. <i>Tropenmed Parasitol</i>. 1982;33(3):191-194.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/7135477/pubmed\" target=\"_blank\" id=\"7135477\">7135477</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hotez PJ, &ldquo;Hookworm Disease in Children,&rdquo; <i>Pediatr Infect Dis J</i>, 1989, 8(8):516-20.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/2671907/pubmed\" target=\"_blank\" id=\"2671907\">2671907</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"7596637\"></a>Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. <i>Parasitology</i>. 1995;110(pt 5):529-533.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/7596637/pubmed\" target=\"_blank\" id=\"7596637\">7596637</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vermox (mebendazole) [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals Inc; October 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"22205349\"></a>Wi&#347;niewska-Ligier M, Wo&#378;niakowska-G&#281;sicka T, Sobolewska-Dryja&#324;ska J, Markiewicz-J&oacute;&#378;wiak A, Wieczorek M. Analysis of the course and treatment of toxocariasis in children-a long-term observation. <i>Parasitol Res</i>. 2012;110(6):2363-2371.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-drug-information/abstract-text/22205349/pubmed\" target=\"_blank\" id=\"22205349\">22205349</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9594 Version 113.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F46303332\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F191554\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F191598\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F191557\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F191577\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F191558\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F13906823\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F13906824\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F46303333\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F20452591\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms: Canada\" href=\"#F13880659\" class=\"outlineLink\">Dosage Forms: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Prescribing and Access Restrictions\" href=\"#F49296536\" class=\"outlineLink\">Prescribing and Access Restrictions</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F803167\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F191534\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25730778\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F9500697\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F191526\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F191537\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F191523\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299650\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F191528\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F191549\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13386518\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F191540\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F191531\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F191522\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F191536\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F46312663\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F191542\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9594|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=mebendazole-patient-drug-information\" class=\"drug drug_patient\">Mebendazole: Patient drug information</a></li><li><a href=\"topic.htm?path=mebendazole-pediatric-drug-information\" class=\"drug drug_pediatric\">Mebendazole: Pediatric drug information</a></li></ul></div></div>","javascript":null}